Adults aged 18 years or older who have hand and/or foot eczema (atopic dermatitis), may qualify for this clinical research trial and receive investigational injected treatment (active study drug) or placebo.

Eligible participants must have a diagnosis of chronic atopic hand and/or foot dermatitis for at least 1 year.  Atopic dermatitis (AD) must be present in at least 2 of the 4 mentioned anatomical areas: left hand, right hand, left foot, or right foot.  Participants must have overall moderate-to-severe disease in the hands/feet, along with a documented history of inadequate response to topical corticosteroids (TCS) within 6 months, or use of TCS is medically inadvisable.

Participants will have regular visits with an experienced research team.  There is no cost to participate, and participants will be reimbursed for study-related expenses.  Individuals will be asked to visit the study centre about 8 times over a period of about 32 weeks.

Please complete the form below to see if you are eligible for this trial.

If you have any questions/queries regarding this trial please email | [email protected]